SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $975,832 | +162.5% | 1,049,169 | -1.2% | 0.00% | – |
| Q4 2022 | $371,792 | -30.5% | 1,062,261 | +0.1% | 0.00% | – |
| Q3 2022 | $535,000 | -39.5% | 1,061,173 | -0.5% | 0.00% | – |
| Q2 2022 | $885,000 | -64.9% | 1,066,092 | -37.8% | 0.00% | – |
| Q1 2022 | $2,519,000 | -47.4% | 1,713,759 | -1.3% | 0.00% | – |
| Q4 2021 | $4,793,000 | -51.3% | 1,736,557 | -0.3% | 0.00% | – |
| Q3 2021 | $9,837,000 | -34.7% | 1,740,942 | +24.0% | 0.00% | – |
| Q2 2021 | $15,068,000 | -47.5% | 1,404,284 | +9.3% | 0.00% | -100.0% |
| Q1 2021 | $28,716,000 | -46.2% | 1,284,848 | +15.6% | 0.00% | -50.0% |
| Q4 2020 | $53,403,000 | – | 1,111,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 740,740 | $35,578,000 | 13.90% |
| Flagship Pioneering Inc. | 10,370,369 | $498,089,000 | 9.07% |
| Monashee Investment Management LLC | 561,628 | $26,975,000 | 3.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 567,460 | $26,061,000 | 2.31% |
| Avidity Partners Management LP | 688,000 | $33,045,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 225,000 | $10,807,000 | 0.76% |
| Artal Group S.A. | 276,000 | $13,256,000 | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 662,227 | $31,807,000 | 0.16% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,485,185 | $71,333,000 | 0.11% |
| Perceptive Advisors | 125,000 | $6,004,000 | 0.06% |